Medical News

RSS

AI tool can accurately predict colorectal cancer risk in UC-LGD patients

People with ulcerative colitis (UC), a chronic inflammatory bowel disease, are up to four times more likely to develop colorectal cancer than the general population.

17 Feb 2026

JAX-NYSCF collaborates with GSK to advance human cellular models of neurodegenerative disease

The Jackson Laboratory–New York Stem Cell Foundation Collaborative (JAX-NYSCF) today announced a five-year strategic research collaboration with GSK focused on advancing human cellular models of neurodegenerative disease, including Alzheimer's disease.

17 Feb 2026

Musicians experience higher rates of tinnitus, hearing loss, and hyperacusis than non-musicians

A new systematic review and meta-analysis published in Otolaryngology–Head and Neck Surgery, the official journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF), reveals that musicians face substantially higher rates of tinnitus, hearing loss, and hyperacusis compared to non-musicians.

17 Feb 2026

M-PACT sets new standard for pediatric brain tumor diagnostics, treatment monitoring

Liquid biopsies, which test body fluids that contain cancerous material, including circulating tumor DNA (ctDNA), are a noninvasive way to learn about a cancer's biology.

17 Feb 2026

Insilico Medicine and MSK collaborate to discover new drug targets for gastroesophageal malignancies

Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and Memorial Sloan Kettering Cancer Center (MSK) have entered into a collaborative research agreement aimed at discovering new therapeutic targets for gastroesophageal malignancies.

17 Feb 2026

Mayo Clinic collaborates with New Phase Ltd. to install magnetic nanoparticle hyperthermia machine for cancer research

Mayo Clinic collaborated with New Phase Ltd. to install the first magnetic nanoparticle-mediated hyperthermia machine for cancer research in the U.S.

17 Feb 2026

Preoperative combination treatment shows promise for some patients with pancreatic cancer

A new UCLA investigator-initiated study sponsored by the UCLA Health Jonsson Comprehensive Cancer Center has found that adding immunotherapy to standard chemotherapy before surgery is safe and shows promise for some patients with borderline-resectable pancreatic cancer, a disease that has historically been difficult to treat.

17 Feb 2026

Harnessing AI to optimize the development of new protein manufacturing processes

Industrial yeasts are a powerhouse of protein production, used to manufacture vaccines, biopharmaceuticals, and other useful compounds.

17 Feb 2026

Calibr-Skaggs and Kainomyx join forces to accelerate development of antimalarial drugs

The Calibr-Skaggs Institute for Innovative Medicines at Scripps Research and Kainomyx, Inc., today announced a new research collaboration to accelerate the discovery and development of next-generation antimalarial drugs.

17 Feb 2026

NCCN publishes new guidelines for management of pediatric soft tissue sarcomas

The National Comprehensive Cancer Network (NCCN) today published new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Soft Tissue Sarcomas.

17 Feb 2026

Myopia may be driven by prolonged close-up focus in low-light environments

For years, rising rates of myopia - or nearsightedness - have been widely attributed to increased screen time, especially among children and young adults.

17 Feb 2026

Fred Hutch scientists reach crucial milestone in blocking Epstein Barr virus

Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is linked to multiple types of cancer, neurodegenerative diseases and other chronic health conditions.

17 Feb 2026

UK aid cuts accelerate dangerous retreat from global health in crisis-affected regions

UK aid cuts demand justice-led solutions such as debt restructuring to repair the harm, writes Katie Husselby, director of Action for Global Health.

17 Feb 2026

Review: Pathogenesis, diagnosis, and management of harlequin ichthyosis

Harlequin ichthyosis (HI) is a rare, severe genetic skin disorder caused by ABCA12 mutations, leading to defective lipid transport and loss of skin barrier function.

17 Feb 2026

Study reveals how body image evolves for people learning to use robotic prosthetics

The way we understand the movement of our own bodies plays an important role when learning physical skills, from sports to dancing.

17 Feb 2026

A yeast-derived genetic tool offers hope for mitochondrial disorders and cancer

Nucleotide synthesis-the production of the basic components of DNA and RNA-is essential for cell growth and division.

17 Feb 2026

From liquid handling to sample storage

PulpFixin®, a materials science company focused on replacing single-use plastics in life science laboratories, will debut a slate of new automation-ready, compostable lab products at the 2026 SLAS International Conference and Exhibition in Boston, expanding its footprint across liquid handling, sample identification and cold storage workflows.

From PulpFixin 17 Feb 2026

Redefining cardiovascular care for women

Cardiovascular disease (CVD) remains the leading cause of death for women across the globe, yet significant progress has been made in prevention, diagnosis and management thanks to more sex-specific research, as noted in a special Go Red for Women issue of Circulation, the American Heart Association's flagship, peer-reviewed scientific journal, published today.

17 Feb 2026

Canadian study reveals how COVID-19 lockdowns masked child maltreatment

Hospital admissions for maltreatment of children under the age of 2 years declined 31% during the 16-week lockdown at the start of the COVID-19 pandemic, returning to prepandemic levels after restrictions lifted, according to new research published in CMAJ (Canadian Medical Association Journal).

17 Feb 2026

Bioengineered E. coli bacteria can now produce rhododendron-derived drugs

Bioengineered E. coli bacteria can now produce a group of compounds with anticancer, anti-HIV, antidiabetic and anti-inflammatory activities.

17 Feb 2026

Previous
1
...
3
4
5
6
7
8
9
...
17864
Next

Medical News

AI tool can accurately predict colorectal cancer risk in UC-LGD patients

JAX-NYSCF collaborates with GSK to advance human cellular models of neurodegenerative disease

Musicians experience higher rates of tinnitus, hearing loss, and hyperacusis than non-musicians

M-PACT sets new standard for pediatric brain tumor diagnostics, treatment monitoring

Insilico Medicine and MSK collaborate to discover new drug targets for gastroesophageal malignancies

Mayo Clinic collaborates with New Phase Ltd. to install magnetic nanoparticle hyperthermia machine for cancer research

Preoperative combination treatment shows promise for some patients with pancreatic cancer

Harnessing AI to optimize the development of new protein manufacturing processes

Calibr-Skaggs and Kainomyx join forces to accelerate development of antimalarial drugs

NCCN publishes new guidelines for management of pediatric soft tissue sarcomas

Myopia may be driven by prolonged close-up focus in low-light environments

Fred Hutch scientists reach crucial milestone in blocking Epstein Barr virus

UK aid cuts accelerate dangerous retreat from global health in crisis-affected regions

Review: Pathogenesis, diagnosis, and management of harlequin ichthyosis

Study reveals how body image evolves for people learning to use robotic prosthetics

A yeast-derived genetic tool offers hope for mitochondrial disorders and cancer

From liquid handling to sample storage

Redefining cardiovascular care for women

Canadian study reveals how COVID-19 lockdowns masked child maltreatment

Bioengineered E. coli bacteria can now produce rhododendron-derived drugs

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News